Posted on :
10 Jul, 2014
10 Jul, 2014
Adcock Ingram began as the EJ Adcock Pharmacy in Krugersdorp 120 years ago. Adcock Ingram was listed on the main trading board of the JSE in 1950 before it became a wholly-owned subsidiary of Tiger Brands and was subsequently delisted from the JSE in 2000. After the unbundling from Tiger Brands, Adcock Ingram re-listed on the JSE in August 2008 at a share price of R33.50 with approximately 172.6 million ordinary shares in issue.
The Company has a market capitalisation of about R9 billion and occupies a 10% share of the private pharmaceutical industry in South Africa. The unbundling from Tiger Brands and subsequent listing presented Adcock Ingram with opportunities that enabled us to drive our vision of being recognised as a leading, world-class, branded healthcare company. The Company looks forward to pursuing organic growth opportunities and acquisitions in selected markets, developing exportable competencies, and implementing meaningful Broad Based Black Economic Empowerment (BBBEE) within the business.
The Company has two businesses; each delivering essential services to a wide customer base:
Adcock Ingram provides an extensive range of branded and generic prescription and OTC products in a broad range of therapeutic classes such as: analgesics, allergy, cardiovascular, central nervous system, dermatology, ear/nose/eye preparations, feminine health, gastrointestinal, vitamin, mineral and energy supplements as well as a selective range of personal care products. In generics, the Company markets a broad range of affordable products under the corporate brand. In branded products, the Company markets many well-recognised leading brands such as Adco Dol, Allergex®, Bioplus®, Citro-Soda®, Corenza® C, Myprodol®, Panado®, Syndol, vita-thion® and Unique Formulations, as well as a diverse range of brands on behalf of our international partners.
Adcock Ingram Critical Care is South Africa’s largest supplier of hospital and critical-care products, blood systems and accessories as well as products used for renal dialysis and transplant medication. This business unit has a 60 year relationship with US-based Baxter International.
Imagine touching the lives of millions! Expect more from your career and reach beyond the ordinary to make an impact on something greater than the bottom line. At Adcock Ingram we strive to add value to the lives of people. By choosing a career with us you’ll be playing a pivotal role in critical issues facing healthcare today. You will have the unique opportunity to innovate, develop and implement value adding strategies.
Our Company culture is one that actively promotes and embraces our Adcock Ingram PRIDE values of passion, respect, innovation, development and execution. We value our employees and recognise their need to develop both personally and professionally so we consistently offer learning and development opportunities to all employees in a variety of professional fields and operational areas.
As one of the leading South African pharmaceutical company’s operating in South Africa, Africa and India we offer a wide range of careers in a variety of environments. Whether you choose an opportunity in Research and Development, manufacturing, quality assurance and control, logistics, customer service, marketing, sales, regulatory affairs, legal, human capital, finance and administration or information technology you will contribute to the next generation of medicines — the breakthroughs that will make better health a reality for millions now and in the future.
We are constantly on the lookout for these scarce skills in our industry — experienced pharmacists and supply chain professionals, experienced artisans for our manufacturing divisions and individuals with medical experience for our sales and marketing divisions.